Vaisala Xweather’s Annual Lightning Report reveals lightning activity in the U.S. surged to an eight-year high in 2025, with ...

TAIPEI (Taiwan News) — A 10-member European Parliament delegation arrived in Taiwan on Sunday for a six-day trip.

Additional details regarding the amended equity incentive plan are set out in the Company’s management information circular dated October 16, 2025, which is available on the Company’s profile on ...

Allot’s CEO, Eyal Harari will be presenting live on Wednesday, January 14, 2026 at 11:00a.m. ET. The presentation will also be webcast at that time. To watch the webcast, please visit either a link on ...

Zenas BioPharma, Inc. (“Zenas,” “Zenas BioPharma” or the “Company”) (Nasdaq: ZBIO), a clinical-stage global biopharmaceutical company committed to being a leader in the development and ...

Mollo Seltzers (including new Blackberry and Wild Berry Açaí four‑packs), Mollo 10, Orchard Chill’r, and XMG beverages are ...

Company to seek FDA alignment on global Phase 3 program replicating Phase 2b design ...

WALTHAM, Mass., Jan. 05, 2026 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced that the company will present at the 44 th Annual J.P. Morgan Healthcare Conference on ...

Halozyme is a biopharmaceutical company advancing disruptive solutions to improve patient experiences and outcomes for emerging and established therapies.

The U.S. Food and Drug Administration (FDA) has cleared Crescent’s IND for CR-001, and Crescent’s partner Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (“Kelun-Biotech”) has received IND approval ...

About Mobix Labs, Inc. Mobix Labs, Inc. (Nasdaq: MOBX) is a fabless semiconductor company delivering advanced connectivity solutions for defense, aerospace, 5G, and other high-reliability markets.

Sionna Therapeutics, Inc. (Nasdaq: SION), a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for cystic fibrosis (CF) by developing novel medicines ...